Yersinia pestis, the infective agent of bubonic and pneumonic plague, has caused widespread loss of human life during recurrent pandemics. Y. pestis still infects rodent populations in large geographic zones where Y. pestis is endemic, and there are cases of human plague reported annually (15, 19, 56) . Y. pestis and the closely related food-borne pathogens Yersinia pseudotuberculosis and Yersinia enterocolitica share a 70-kb plasmid carrying genes that encode a major set of proteins involved in pathogenic properties that compromise the host immune system (60) . These include a type 3 secretion system (T3SS) that at mammalian body temperature delivers a set of six Yersinia outer protein (Yop) effector proteins into host cells once the bacteria contact host target cells. Enzymatic and cell biological mechanisms of five of the Yops, YopH, YopE, YopT, YpkA/YopO, and YopJ, have been elucidated. YopJ interferes with signal transduction through acetyltransferase activity but is not required for virulence in either a mouse model of systemic plague (57) or mouse and rat models of bubonic plague (28, 65) . In tissue culture infection models, YopH, YopE, YopT, and YopO have been shown to antagonize focal complex formation and activity of Rho family GTPases and synergistically inhibit phagocytosis by mammalian cells. YopH and YopE have been shown to be crucial for lethality in a mouse model of systemic plague (intravenous [i.v.] infection), and a ⌬yopH strain is attenuated for both bubonic and pneumonic plague (9) . In addition, Y. pestis virulence proteins, such as the surface fibrils F1 and PsaA, have antiphagocytic effects and also have been found to contribute to virulence in systemic plague (7, 31) . Accordingly, Y. pestis is believed to exist predominantly in an extracellular location in vivo, although initially the bacteria might invade resting tissue macrophages (Ms) and dendritic cells (DCs), based on assays of mouse spleens in the systemic phase of bubonic plague (33) . The intracellular versus extracellular locations of Y. pestis during the peripheral phases of plague on skin or in the lung have not yet been studied.
It is believed that tissue Ms, DCs, and polymorphonuclear leukocytes (PMNs) are early target cells for Yop delivery in vivo, because these cells are present before or soon after infection begins and function to initiate the innate defenses that are undermined by Yops. Consistent with this hypothesis, Y. pestis has been found in association with alveolar Ms early during lung infection of mice (6) and likewise in association with Ms, DCs, and PMNs in the spleens of mice infected i.v., and YopM can be injected into these cells (34) . However, it is becoming clear that spleens and lungs present distinctly different inflammatory environments when infected by Y. pestis, with PMNs migrating rapidly into spleens infected by the i.v. route but not appearing in lungs until 36 h after intranasal (i.n.) infection (27, 58) . Accordingly, some virulence properties required for lethality of systemic plague are not required in pneumonic plague. Examples are the capsular fibril F1 and the antiphagocytic adhesin PsaA (7, 11, 12) . There is no information yet on the target cells or relative importance of Yops other than YopH in pneumonic or bubonic plague.
The sixth effector Yop, YopM, is essential for virulence in the mouse model of systemic plague: in C57BL/6 mice, a
YopM
Ϫ strain of Y. pestis KIM5 is reduced in lethality by at least 4 orders of magnitude (29) . However, the function of YopM has not been defined. YopM is a 46.2-kDa acidic protein made up almost entirely of 15 repeats of a 19-residue leucine-rich repeat motif (30) . The YopM monomer is horseshoe shaped and has the potential to form tetramers in which the monomers stack together to form a hollow cylinder; however, the form that YopM assumes within the mammalian cell is not known (16) . After delivery to the host cell cytoplasm, YopM localizes to the nucleus in a process that is facilitated by vesicular trafficking (53) . YopM was reported to form a complex with the serine/threonine kinases PRK2 (protein kinase C-related kinase 2) and RSK1 (90-kDa ribosomal S6 kinase) in HEK293 cells infected with Y. pseudotuberculosis (36) , leading to activation of both kinases. However, the biological significance of this complex is not known. There is no visible effect of delivery of YopM into cultured cells, and microarray analysis of M-like cell lines infected with Y. enterocolitica having or lacking YopM also has not yielded any clue to YopM's mechanism of action (21, 50) .
Because these and other in vitro approaches to defining the pathogenic mechanism of YopM have not been fruitful, we have begun to characterize YopM's effects in vivo. Previously we found that YopM was still required for lethality in i.v. infected SCID mice, showing that YopM's virulence mechanism does not require B or T cells and indicating that early in systemic plague, YopM's main function is to counteract a component of innate immunity (25) . A striking YopM-specific effect during systemic plague in wild-type C57BL/6 mice was the depletion of natural killer (NK) cells from the spleen and a reduction of NK cell numbers in blood, suggesting that YopM might cause a loss of the NK cell compartment during systemic plague. Correlated with this effect, there was a YopM-associated loss of mRNA for gamma interferon (IFN-␥) by NK cells in infected spleens and diminished expression of mRNAs in splenic Ms for cytokines that are required for viability and activation of NK cells (interleukin 15 , IL-18, and IL-12). These findings supported the hypothesis that YopM may function to inhibit IFN-mediated activation of Ms through the depletion of NK cells (25) .
In this study, we tested the hypothesis that NK cells are critical for controlling Y. pestis pathogenesis early in plague and that NK cells are the primary target of YopM. We characterized infection dynamics and leukocyte populations in both the liver and spleen during systemic plague in mice ablated for Ms/DCs or for Gr1 ϩ cells. The data point to PMNs and inflammatory monocytes as critical cells affected by YopM and to Ms/DCs as an important early reservoir for bacterial growth. Consistent with a role in undermining acute inflammation, YopM was found to be important for the lethality of bubonic plague, but not pneumonic plague.
MATERIALS AND METHODS
Bacterial strains and in vitro cultivation. Bacterial strains and plasmids used in this study are listed in Table 1 . This study employed strains from the two most recently evolved groups of Y. pestis populations (1), Y. pestis KIM5 (molecular grouping 2.MED), an isolate from Iran, and Y. pestis CO92 (1.ORI), isolated in the United States and representative of strains causing the current pandemic. The genomes of both strains have been sequenced (13, 43) . Y. pestis KIM5 and the ⌬yopM 1 derivative KIM5-3002, in which the yopM ORF (including the stop codon) and 2 bp upstream were deleted, lack the chromosomal pgm locus and are conditionally virulent: they are attenuated by peripheral routes of infection but are virulent by the i.v. route of infection, which bypasses the requirement for a siderophore-based iron acquisition mechanism encoded in this locus (25, 61) . Y. pestis CO92.S6 is fully virulent.
Escherichia coli was routinely grown in Luria-Bertani broth or agar (38) at 37°C. Y. pestis KIM5-derived strains were routinely grown at 26°C in heart infusion broth (HIB) (Difco Laboratories) and harvested in exponential phase at an A 620 of 0.8 to 1.2. Cells were centrifuged at 23,281 ϫ g and 4°C for 5 min, washed, and diluted in phosphate-buffered saline (PBS). Samples of the diluted cells were plated on tryptose blood agar (Difco Laboratories) and incubated at 30°C for 2 days to determine the dose. Y. pestis CO92-derived strains were grown at 28°C or 37°C as indicated in HIB supplemented with 2.5 mM CaCl 2 and 0.2% (48) were deleted from pCD2Ap of the Y. pestis CO92 derivative Y. pestis CO99-3015.S6. Briefly, primers LF up (5Ј-ACATTAGAGCTCTGCCTGTCTCCGTTGTTG-3Ј) and LF down (5Ј-TA CTATCTGCAGTGTATGGCCGCAGAGT-3Ј) were used to copy 1,180 bp of DNA upstream of the deleted locus by PCR, and primers RF up (5Ј-TGCTGC AGACGCAAGAGCGTTCAT-3Ј) and RF down (5Ј-ATCTCTCGAGACGCC ACCGTTGATTA-3Ј) were used to copy 1,230 bp of downstream DNA. The upstream and downstream DNAs were cloned into pLD55 as respective SacI/PstI and PstI/XhoI PCR products to create the allelic exchange plasmid p⌬yopM-2 in Escherichia coli DH5␣ pir. The deletion was moved into pCD2Ap by allelic exchange as previously described (37, 42) . The deletion did not remove any ORFs other than yopM, and its upstream boundary was 196 bp downstream from the stop codon of the nearest potential ORF (48) . The deletion extended 1 bp downstream of the yopM stop codon (similar to the ⌬yopM 1 mutation in Y. pestis KIM, which deletes the stop codon but no downstream bases). The resulting yopM deletion was confirmed by PCR. The absence of YopM expression in the ⌬yopM 2 strain but normal levels of expression and secretion of YopH and LcrV with appropriate regulation by calcium in the medium were confirmed by immunoblot analysis of whole cells and culture supernatants. Strains with the two mutations, ⌬yopM 1 in the KIM5 background and ⌬yopM 2 in the CO92 background, are believed to have the same phenotypes, because the mutations are both well separated from upstream and downstream ORFs, but because they are not identical, we have given them different allelic designations.
pCD2Ap ⌬yopM 2 was moved into Y. pestis CO92.S1 by electroporation of total plasmid DNA from Y. pestis CO99-3015.S11 in biosafety level 3 containment. Transformed strains were selected for Cb resistance and screened for the Pgm ϩ and Lcr ϩ phenotypes. Pgm ϩ Lcr ϩ isolates were subcultured at 26°C with shaking at 200 rpm in TMH plus Cb for ca. 10 generations and then for 2 h in TMH with or without 2.5 mM CaCl 2 (no Cb); then they were incubated at 37°C for 4 h. Cells and culture medium were analyzed by immunoblotting for expression and secretion of Yops as described previously (45) . The resulting Y. pestis strain CO92.S19 and the YopM ϩ strain CO92.S6 were handled only in biosafety level 3 containment with select agent security.
Infection of mice and measurement of bacterial viable numbers in tissues. All animal experiments in this study were reviewed and approved by the University of Kentucky Institutional Animal Care and Use Committee. For studies with Y. pestis KIM5 and KIM5-3002, female C57BL/6N.HSD mice (Harlan Sprague Dawley, Inc.), 6 to 8 weeks old, were anesthetized with an isoflurane-oxygen mixture by a rodent anesthesia machine. Fifty microliters (400 CFU) of bacterial suspension was injected in each mouse i.v. via the retro-orbital plexus. This was above the 50% lethal dose (LD 50 ) for the parent strain and below that for the ⌬yopM 1 mutant. The two bacterial strains grew similarly for the initial 24 to 48 h of infection (25) (see Fig. 1) ; accordingly, the innate host responses were elicited by similar bacterial numbers, and differences would be due to the presence or absence of YopM and not to nonspecific factors. Groups of three mice per strain per time point were humanely killed by CO 2 inhalation followed by cervical dislocation, and their spleens and livers were weighed, transferred to a sterile bag containing 5 ml of PBS, and placed on ice. The tissues were homogenized in a Stomacher 80 lab blender (Tekmar Co.) for 60 s with high speed. The liver and spleen homogenates were diluted in PBS and plated to measure the bacterial burden in the organs.
For infection with Y. pestis CO92 strains, the mice were anesthetized with ketamine (100 mg/kg of body weight; IVX Animal Health) and xylazine (10 mg/kg; Butler Co.) given intraperitoneally (i.p.). Bacterial doses were made in 100 l of PBS for intradermal (i.d.) infection and administered with a 1-ml tuberculin syringe fitted with a retractable 26-gauge needle (Becton Dickinson and Company). For i.n. infection, a 20-l volume of bacteria in PBS was instilled into the nares from a plastic micropipette tip. The effect of xylazine was then reversed by subcutaneous injection of yohimbine (2 mg/kg) (Ben Venue Laboratories), and the mice were treated with an optical lubricant before being returned to their cages.
Tests of virulence in mice. Ablation of PMNs and inflammatory monocytes was done as described previously (49) . Briefly, anti-Gr1 MAb (which recognizes both populations of cells as well as memory CD8 ϩ T cells, plasmacytoid DCs, and other small populations of regulatory myeloid cells [14] ) was prepared from B-cell hybridoma line R6-8C5 (DNAX Research Institute) and partially purified using ammonium sulfate precipitation. Anti-Gr1 MAb or rat IgG was injected i.p. at 100 g/mouse on days Ϫ1 and 1 of Y. pestis infection. Flow cytometric analysis of PMNs in these mice and in mock-treated mice employed MAb 1A8, which detects a PMN-specific Ly6G epitope that is distinct from the common epitope on Ly6G and Ly6C that is detected by MAb R6-8C5. Ms/monocytes were analyzed as Ly6G Ϫ CD11b ϩ cells that did not carry the DC marker CD11c. Systemic ablation of Ms/DCs was mediated by liposome-encapsulated clodronate (clodronate-liposomes). The liposomes were prepared as previously described (62) . Dichloromethylene diphosphonate (clodronate) was a gift of Roche Diagnostics GmbH, Mannheim, Germany. Phosphatidylcholine was obtained from Lipoid GmbH, Ludwigshafen, Germany. Cholesterol was purchased from Sigma-Aldrich. Mice in ablation groups or control groups were injected, respectively, with 200 l clodronate-liposomes or liposome-encapsulated PBS (PBSliposomes) by the i.v. route into the retro-orbital plexus 18 h prior to Y. pestis infection and on day 1 postinfection (p.i.). The extent of ablation was evaluated by flow cytometry with analysis for CD11b (Ms, monocytes, PMNs, some DCs), CD11c (mainly DCs), and Ly6G (mainly PMNs).
Two tests employed transgenic MaFIA (M Fas-induced apoptosis) mice on a C57BL/6 background (10). These mice were bred and confirmed by PCR to be homozygous for the inducible suicide transgene before use in experiments. Mice were between 5 and 8 weeks old. Both sexes were used and distributed equally among treatment groups. These mice can be ablated for cells of the M/DC lineage by treatment with the dimerizer drug AP20187 (gift of Ariad Pharmaceuticals, Inc.). Seven days prior to infection, the ablation regimen was initiated by i. Ϫ cells (non-T cells) for Gr1 (inflammatory monocytes and PMNs, some DCs) and F4/80 (Ms and monocytes).
Flow cytometry. Cells isolated from livers and spleens were analyzed in a FACSCalibur flow cytometer (Becton Dickinson FACS Systems). Briefly, the spleens were placed in sterile bags containing 5-ml volumes of PBS and then processed with the Stomacher 80 lab blender for 60 s at high speed. The homogenate was centrifuged (913 ϫ g for 10 min) and resuspended in 2 ml red blood cell (RBC) lysis buffer (150 mM NH 4 Cl [pH 7.2]). After 2 min, the reaction was terminated by the addition of 8 ml of PBS. The cell suspensions were filtered through a 40-m-pore-size cell strainer (Becton Dickinson and Company) to remove connective tissue, centrifuged (913 ϫ g for 10 min), and resuspended in PBS containing 1% (wt/vol) bovine serum albumin (BSA) and 0.1% (wt/vol) sodium azide (PBS-BSA-azide).
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To process livers, finely minced livers were placed into sterile bags containing 10-ml volumes of RPMI 1640 (Life Technologies Inc.) with 10% fetal bovine serum (ATCC) and processed with the Stomacher 80 lab blender for 60 s with high speed. The homogenates were incubated with DNase I (160 U/ml; SigmaAldrich) and collagenase (400 U/ml; Invitrogen) for 30 min in a 37°C water bath with shaking at 125 rpm. After filtration through a 40-m-pore-size cell strainer, cell suspensions were washed once with ice-cold PBS-BSA-azide and resuspended with 5 ml of 33.8% Percoll (Amersham Bioscience, GE Healthcare), followed by a 12-min centrifugation at 693 ϫ g. The cells in the bottom layer were collected, washed with PBS, and treated with RBC lysis buffer. Nonlysed cells were resuspended in PBS-BSA-azide.
The following antibodies were purchased from BD Pharmingen, Inc.: allophycocyanin (APC)-conjugated anti-CD11c, APC-conjugated anti-NK1.1, APC-conjugated anti-CD62L, FITC-conjugated anti-CD3, FITC-conjugated anti-CD11b, FITC-conjugated anti-DX5 (CD49b), FITC-conjugated anti-mouse IgG2a, indodicarbocyanine-or APC-conjugated anti-F4/80, phycoerythrin (PE)-conjugated anti-B220, PE-conjugated anti-CD8, PE-conjugated anti-DX5, PE-conjugated anti-Ly6G, PE-conjugated anti-NK1.1, PE-conjugated anti-CD86, PE-conjugated anti-Gr1 and PE-conjugated anti-Ia b . To gate out apoptotic or dead cells, ethidium monoazide (Sigma) was used for viability staining. To evaluate NK-T cells, mCD1d/PBS-57 (mouse CD1d loaded with PBS-57, an analogue of ␣-galactosylceramide) (APC conjugated) was used (provided by the NIH Tetramer Core Facility).
Prior to staining, the cells were counted, and samples were adjusted to 5 ϫ 10 5 cells per 100 l. All samples were stained with ethidium monoazide to identify dead cells. In the presence of the appropriate combinations of antibodies, the cells were incubated on ice for 30 min, with the last 10 min of incubation in the light. After the cells were washed in PBS, they were resuspended in ice-cold PBS containing 4% (wt/vol) paraformaldehyde (pH 7. Table 2 . Histopathology. Portions of livers, skin, or lung were placed in 10% buffered formalin, processed through graded series of alcohol and xylene solutions, and then embedded in paraffin. Sections stained with hematoxylin and eosin were examined and photographed with an Axiophot microscope (Carl Zeiss, Inc.).
Statistical analysis. Infection experiments with flow cytometric, histopathology, and CFU analyses were conducted at least twice with at least three replicate mice per group. The data from the replicate experiments were then pooled for analysis of significance. Significance of differences among groups was assessed by the Student unpaired two-tailed t test. Values for which P Ͻ 0.05 were considered significant. Data are presented as the mean values Ϯ standard deviations (SDs), and the numbers of mice used for each datum point are given in the figure legends. Virulence tests measuring lethality were conducted at least twice with four to eight mice per group and three or four dosage groups. Probit analysis was applied to log-transformed pooled data (17; implemented through BioStat 2008 5.1.1.0 [by A. Simachov at AnalystSoft]), and the results are expressed as the mean Ϯ standard error of the mean with 95% confidence limits given in parentheses.
RESULTS
YopM-dependent NK cell depletion is delayed in the liver than in the spleen. We are using a systemic model of plague to identify differences in the early host response that are derived from the presence versus absence of YopM in the infecting Y. pestis strain. This model is relevant to the later phases of both bubonic and pneumonic plague, when the bacteria disseminate to the liver and spleen, and it offers the strong advantage of a synchronous infection that can be readily quantified. The time courses for growth of the parent Y. pestis KIM5 are similar in the livers and spleens of mice with systemic plague, and the timing of growth and clearance of the ⌬yopM 1 mutant KIM5-3002 are also similar for the two organs (25) . We hypothesized that the host mechanisms that control the growth patterns are similar in the two organs. In previous work (25) , several leukocyte populations had been characterized in the spleens and blood of mice with systemic plague, but these cells had not been tested for their importance in limiting the growth of the YopM Ϫ mutant. In this work we sought to identify cell types that were required for controlling growth of YopM Ϫ Y. pestis in the liver and spleen. We first tested whether the YopMspecific NK cell depletion seen previously in spleen was truly a global effect, occurring in the two major organs (liver and spleen) colonized by Y. pestis early in systemic plague. Groups of three C57BL/6 mice were infected i.v. with 400 CFU of Y. pestis KIM5 or KIM5-3002. This dose was intermediate between the LD 50 s for these two strains (29) . Organs were harvested on days 2, 4, and 5 p.i. Figure 1A shows that the growth of the YopM Ϫ mutant KIM5-3002 in the liver and spleen was progressively slower and that the bacteria were cleared more rapidly from both organs than the parent strain KIM5 was. In spleens, a YopM-dependent loss of NK1.1 ϩ CD3 Ϫ NK subgroups was observed during infection as previously reported (Fig. 1B) . Neither DX5 ϩ NK1.1 Ϫ NK cells nor CD1d-restricted NK-T cells showed any YopM-dependent changes, although the percentages of these latter cells dropped by ca. twofold between day 2 and day 4 p.i. in mice infected by either Y. pestis strain (data not shown). In contrast, there was no YopM-related depletion of any NK cell population in the liver (Fig. 1C shows the major NK population in the liver). These data indicated that YopM-specific depletion of NK cells was not systemic and suggested that loss of NK cells may not be critical for the virulence effect of YopM.
Antibody-mediated ablation of NK cells does not bypass the ⌬yopM 1 mutation. If NK cells are responsible for growth restriction of the Y. pestis ⌬yopM 1 mutant strain, this growth limitation should be relieved in mice lacking NK cells. We tested this hypothesis by comparing the growth of parent and mutant Y. pestis in mice ablated for NK cells. On day 1 prior to infection and days 1 and 3 p.i., we i.p. injected anti-NK1.1 MAb or rat IgG into each mouse in the ablation groups or mock treatment groups, respectively. Mice were then infected by the i.v. route with 400 CFU and humanely killed on days 2, 4, and 5 p.i. for analysis of CFU, leukocyte populations, and histopathology in spleen and liver. About 90% of NK1.1 ϩ CD3 Ϫ cells were ablated from both the spleen and liver by the initial antibody treatment, and the subsequent treatments maintained very low levels of NK cells during the experiment (Fig. 2A) . However, successful NK cell ablation failed to relieve the re- stricted growth of the Y. pestis KIM5-3002 ⌬yopM 1 mutant in either organ (Fig. 2B) . Histopathological analysis of the livers (day 4 p.i.) in both the KIM5-3002-infected mock-treated or NK cell-ablated mice showed lesions that were similar in character and number (Fig. 2C) . The histopathological appearance was typical of the proinflammatory response that precedes microgranuloma formation in C57BL/6 mice, curbing net growth of the ⌬yopM 1 mutant (25) . While it is conceivable that the NK cells remaining in the anti-NK1.1 MAb-treated mice (Ͻ10%) were sufficient to exert full growth limitation of the ⌬yopM 1 mutant, we consider it more likely that YopM-dependent NK cell depletion may be a side effect caused by the compromised function of other cell types, such as Ms and DCs, in the spleen (25) .
Population dynamics of other innate defense cells during systemic plague. Since NK cells did not prove to be a target of YopM that was critical for virulence, we evaluated leukocyte population dynamics for clues that would point to the cells that are responsible for the in vivo growth defect of YopM Ϫ mutant Y. pestis. Further, because of the large YopM-associated effect on NK cells in the spleen, we performed this analysis in mice ablated for NK cells as well as in mock-treated mice to learn Figure 3 shows that in the spleens of mock-treated mice (left panels), only CD8 ϩ DCs (Fig. 3B ) displayed a reproducible YopM-associated pattern of change in which the numbers of these DCs declined significantly by day 4 of infection by the parent Y. pestis strain but were maintained in mice infected with the ⌬yopM 1 mutant. NK cell ablation did not affect the distribution of any of the DC subgroups in the spleen. In the livers from mock-infected mice (Fig. 3, right panels) , all of the three DC subgroups showed moderate YopM-related change after day 4 p.i., and again, ablation of NK cells did not alter the distribution of DC subgroups, with the exception of one time point for mice infected with the parent Y. pestis. Staining for surface markers of DC activation (CD86 and Ia b ) did not reveal any significant differences between ⌬yopM 1 mutant and parent Y. pestis infections (data not shown) as indicated by MFI. Figure 4A shows that the percentage of PMNs (Ly6G 
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CD11b ϩ ) increased during infection of mock-treated mice by both Y. pestis strains, peaking on day 2 p.i. Thus, the influx of PMNs from blood was not affected by the presence of YopM in the infecting strain. In contrast, there was a significant and reproducible difference in the M/monocyte populations (Ly6G Ϫ CD11b ϩ ) in the spleen on days 2 and 3 p.i., but this was not observed in the liver (Fig. 4B ). The cells in the peak population had high expression levels of CD11b, when analyzed as MFI, and thus likely were newly arrived monocytes (data not shown). Accordingly, the increase in Ms in mice infected with the ⌬yopM 1 mutant but not the parent Y. pestis may reflect an effect of YopM on monocyte influx into the spleen but does not obviously explain the virulence effect of YopM in the liver. Gr1 ؉ cells are necessary for the clearance of the ⌬yopM 1 mutant strain. To evaluate the importance of PMNs and the inflammatory monocyte subset of monocytes (20) in the pathogenic mechanism of YopM, we ablated these cells in vivo with anti-Gr1 (Ly6G/Ly6C) MAb given 1 day before and 1 day after infection with the ⌬yopM 1 mutant or the parent Y. pestis strain. Figure 4A shows that the ablation protocol removed over 90% of the Gr1 ϩ PMNs from both the liver and spleen, and Fig. 4B shows that the increase in monocytes in both organs was also abolished or delayed by anti-Gr1 treatment. In the mock-treated mice, the YopM-associated growth defect was exhibited as expected at days 2 and 3 p.i. (Fig. 4C) . Strikingly, the growth defect of the ⌬yopM 1 mutant strain in both the spleen and liver disappeared in the mice treated with anti-Gr1 antibody, and growth of the parent strain was slightly enhanced (Fig. 4C) .
The lesions in livers of mock-treated mice infected with parent Y. pestis were dominated by dissipating acute inflammation on day 3 p.i., whereas those from mice infected with the ⌬yopM 1 mutant contained large numbers of PMNs and Ms (Fig. 4D , top panels) as described previously (25, 41, 58) . However, this histological picture appeared to be in conflict with the results of whole-organ flow cytometry, which showed no significant difference in the percentage of intact PMNs (PMNs that did not stain with ethidium monoazide) in the livers or spleens of mice infected with the two strains of Y. pestis (Fig. 4A) . To address this issue, we visually scored all the lesions in the day 3 p.i. histopathological slides for number, size, and character. We found that infection by the ⌬yopM 1 strain caused fewer but larger foci than those by Y. pestis KIM5. The foci in livers of mice infected by the YopM Ϫ mutant always contained morphologically intact PMNs, whereas the livers from mice infected by the parent strain typically contained a mixture of morphologically intact PMNs and cellular debris (Fig. 4E , bottom panels; illustrated in higher magnification by the top panels in Fig. 4D) . The difference in the foci between the two strains was clear by day 2 p.i. (Fig. 4E , top panels), indicating that there was a YopM-associated difference in PMN integrity or function that correlated with the difference in growth for the parent and YopM Ϫ mutant strains. After ablation of PMNs and inflammatory monocytes, lesions in mice infected by the Y. pestis ⌬yopM 1 mutant morphologically mimicked those of mice infected with the parent strain (Fig. 4D, bottom panels) (Fig. 5A) . In the liver, clodronate failed to reduce the initial number of M-like cells but prevented or delayed the influx of monocytes (Fig. 5A) . Flow cytometric analysis for total CD11c ϩ DCs showed a depletion pattern similar to that of Ms/monocytes (data not shown). Nonetheless, the clodronate treatment strikingly curtailed the number of viable bacteria for both Y. pestis strains in both organs (Fig. 5C ). This effect did not correlate with changes in numbers of PMNs except at day 3 and then only in the spleen (Fig. 5B ). Lesions at day 3 p.i. in the mock-treated mice were similar in appearance to those of other mock-treated mice at the same time p.i. (compare the top panels in Fig. 5D to the top panels in Fig.  4D ). However, in clodronate-treated mice, regardless of the strain they were infected with, only a few small lesions were found, and there was little or no necrosis present. These histopathological findings were consistent with a lower inflammatory status in the mice treated with clodronate-liposomes versus the mice treated with PBS-liposomes (Fig. 5D ). These data showed that clodronate-sensitive cells function to amplify bacterial numbers for Y. pestis with or without YopM, consistent on November 7, 2017 by guest http://iai.asm.org/ with a previous study which suggested that Ms serve as an intracellular reservoir during plague (33) . The liposomes per se are not completely benign, and the total numbers of Ms were reduced in the spleens of mice that were mock treated with PBS-liposomes. We consequently tested a different method for M/DC ablation for its effect on infection by the parent Y. pestis KIM5 strain. Ms/DCs can be conditionally depleted by treating MaFIA mice with a dimerizer drug that initiates Fas-induced apoptosis in these cell types without affecting mature PMNs (10) . Groups of these mice were given dimerizer or were mock treated (treated with mock injection solution), infected by the i.v. route with 200 CFU of the parent Y. pestis, and analyzed for viable numbers of bacteria in the liver and spleen on day 4 p.i. The depletion of CD11b ϩ Ly6G Ϫ cells in dimerizer-treated MaFIA mice was about 95%, and PMNs were not depleted (data not shown). Figure 6 shows that ablation of Ms/DCs by this alternative procedure again resulted in significantly lower bacterial burdens in organs.
Interestingly, in mice treated with clodronate-liposomes, the ⌬yopM 1 mutant still showed restricted growth compared to the parent strain, most prominently in the spleen (Fig. 5C) , and in both the liver and spleen, viable numbers of both Y. pestis strains were controlled. This control correlated with the influx of PMNs, and PMNs likely are responsible for the growth deficit of the YopM Ϫ strain in the mice ablated for nongranulocytic myeloid cells. However, because the clodronate-liposome treatment failed to achieve complete depletion, this experiment did not completely rule out an effect of YopM on nongranulocytic myeloid cells or a role of these cells in controlling bacterial growth.
YopM is required for virulence in bubonic, but not pneumonic, plague. The studies so far had indicated that the virulence effect of YopM in systemic plague is directed against Gr1 ϩ inflammatory cells to promote bacterial growth. To extend our information to peripheral phases of plague, we tested the importance of YopM for lethality in bubonic and pneumonic plague. We used the fully virulent Pgm ϩ Y. pestis CO92.S6 strain for these studies and also deleted YopM and its promoter in this strain background, creating the ⌬yopM 2 strain CO92.S19. It should be noted that the yopM genes of Y. pestis KIM5 and CO92 are identical. The LD 50 of the ⌬yopM 2 strain by the i.n. route was similar to that for CO92.S6 ( Table 3 ), indicating that YopM is not required for lethality of pneumonic plague. It remains to be determined whether the progression of colonization and pathology in pneumonic plague is unaltered by the absence of YopM in the infecting Y. pestis. For experimental bubonic plague, we tested virulence by i.d. injection, as happens during infection by fleabite (51) . By this route, the ⌬yopM 2 mutant strain was ϳ25-fold less lethal than the parent Y. pestis (Table 3 ). These results show that YopM is required for full lethality in bubonic plague, but not pneumonic plague.
The influx of inflammatory cells into lungs does not occur before 36 to 48 h p.i. in pneumonic plague (27) , but it was not known whether there is a rapid inflammatory response in bubonic plague. We hypothesized that PMNs would be recruited early in infected skin if they are a major target cell for YopM's virulence effect and if YopM is required for virulence early in bubonic plague. To test this idea, we harvested the skin surrounding the infection site at 8 h p.i. for histopathological analysis. For comparison, the lungs of mice infected by the i.n. route were also evaluated. Figure 7 shows that a robust influx of PMNs was under way by 8 h p.i. in the skin of mice infected with either Y. pestis strain. In contrast, there was no inflammation present in the lungs at this time or at 24 h p.i. for mice infected by the i.n. route ( Fig.  7 and data not shown). These findings are consistent with a requirement for YopM to counteract the innate inflammatory response in bubonic but not pneumonic plague.
DISCUSSION
The plague virulence protein YopM is known to be delivered to host cells upon contact and in some way to counteract KIM5-3002 (⌬yopM 1 mutant) or the parent strain KIM5. The same doses of liposomes were also given to the mice on day 1 p.i. (A to C) On days 1, 2, and 3 p.i., the percentages of Ms/monocytes (A) and PMNs (B), and numbers of CFU (C) in spleens and livers were determined. Representative flow cytometric scatter plots illustrating the discrimination among cell populations in the spleens from a noninfected mock-treated mouse (top plot) and a noninfected mouse ablated of nongranulocytic myeloid cells (bottom plot) on day 1 (d1) of the experiment are shown to the right of panel A. The data in the graphs represent the averages plus SDs (error bars) for six mice per datum point in panels A and B and from nine and six mice per datum point for the spleen and liver, respectively, in panel C (25) . In the present study, we assessed the importance of NK cells early in systemic plague and found no effect of NK cell ablation on growth of either the parent Y. pestis or the YopM Ϫ mutant strain. In contrast, ablation of Gr1 ϩ cells significantly relieved the growth defect of the YopM Ϫ mutant, and the mutant and parent strains caused similarly necrotic lesions in liver. The relevant Gr1 ϩ cells probably were PMNs, because ablation of Ms/DCs, including Gr1 ϩ inflammatory monocytes, had the opposite effect, of inhibiting growth of both strains accompanied by significantly fewer, smaller, and less necrotic lesion sites in liver. However, we cannot rule between PMNs and inflammatory monocytes in limiting growth of the Y. pestis ⌬yopM 1 mutant strain in the spleen, and both may be involved. Therefore, we hypothesize that YopM interferes with innate immunity through Gr1 ϩ cells instead of NK cells and that Ms/DCs provide a protective environment for Y. pestis in a YopM-independent manner.
Our previous work had mainly analyzed immune cell populations in the spleen. However, the liver is the other organ predominantly infected in the first 3 days of systemic plague, and growth dynamics of Y. pestis in the liver are similar to those in the spleen despite the distinct immune microenvironments in these two organs. For example, the liver, more than the spleen, is a focus for immune surveillance by NK-T cells, which can release IL-4 explosively and other key Th2 cytokines, such as IL-13, in addition to massive amounts of IFN-␥ (5, 40). In our previous study (25), we had not evaluated leukocyte population dynamics in the liver due to the difficulty of separating leukocytes from hepatocytes. In this work, we combined and modified protocols originally developed for obtaining leukocytes from the colon (47) to obtain high-purity preparations of leukocytes from the liver, and these were analyzed by flow cytometry alongside leukocytes from the spleen in mice infected with Y. pestis KIM5 or KIM5-3002. Several tissue-selective changes were found. In the spleen, only NK1. liver was not manifested as a net loss of NK cells but did not rule out the possibility that these cells were lost and rapidly replenished due to preferential homing of NK cells to the liver (26) . To rule on whether NK1.1 ϩ cells were critical for the virulence effect of YopM, we tested whether ablation of NK cells would relieve the growth defect of the YopM Ϫ mutant and found no effect of ablation on viable bacterial numbers of either the parent or the mutant in either the liver or spleen. This finding indicated that NK cells are redundant for YopM's pathogenic mechanism or that NK cell depletion by YopM is an irrelevant secondary effect of YopM.
Interestingly, monocytes failed to be recruited as robustly into the spleens of mice infected with parent Y. pestis as in mice infected by the YopM Ϫ mutant. This effect did not occur in the liver. The difference in monocyte influx could contribute to the YopM-dependent NK cell depletion in the spleen, since Mlike cells are major producers of IL-15, a cytokine that is critical for the maintenance of viability of circulating NK cells (46) . DCs have also been implicated as having a role in NK cell survival and proliferation through cell-to-cell contact and production of cytokines, including IL-15 (64) , and a YopM-induced failure in the cross talk between NK cells and DCs could underlie NK cell depletion in the spleen by YopM. An effect of YopM that decreases IL-15 production by PMNs could also contribute to the YopM-associated loss of NK cells from the spleen. These speculations need to be tested in future work; however, we have confirmed the importance of Ms/DCs for NK cell survival in our system. Depletion of ca. 70% of Mlike cells by clodronate-liposomes eliminated the influx of monocytes into the spleen and liver in mice infected with the YopM Ϫ mutant and ablated 80% of the DCs in the spleen, while eliminating DC influx into the liver. Concomitantly, there was an essentially complete loss of NK1.1 ϩ DX5 ϩ NK cells in both organs (data not shown).
We next examined populations of DCs for changes that might correlate with YopM's effect on bacterial growth, because of the well-established frontline surveillance function of DCs for invading microorganisms or microbial products (3). There is evidence that Y. pestis selectively engages Ms, DCs, and PMNs for Yop injection through the T3SS (34) , and the migration of DCs to draining lymph nodes is inhibited when the infecting Y. pestis strain contains the virulence plasmid carrying genes encoding Yops (63) . We monitored the numbers of three major subgroups of DCs in mice infected by the parent or YopM Ϫ Y. pestis. In the spleen, only the numbers of CD8 ϩ DCs displayed a YopM-specific change, decreasing fourfold by day 4 p.i. These DCs are located in the T-cell area, where they can internalize apoptotic cells, selectively present antigens to both CD4 ϩ and CD8 ϩ T cells, and elicit a Th-1 response through production of IL-12 and IFN-␥ (2). In the liver, all three subgroups of DCs decreased in numbers when the infecting Y. pestis strain contained YopM. However, the YopM-related changes in the numbers of CD8 ϩ DCs in spleens or DCs in livers only became significant relatively late in infection (days 4 to 5 p.i.) compared to the time when the growth difference between the two Y. pestis strains became significant (day 2 or 3 p.i.). Accordingly, although DCs likely are important in plague and YopM may have a role in modulating the function of these cells, an inhibitory effect of YopM on another cell type is likely to be responsible for promoting early bacterial growth.
PMNs and inflammatory monocytes have received little in vitro study compared to Ms for their role in the pathogenic mechanisms of Yops, although PMNs are thought to be important in controlling bacterial numbers early in plague (22, 52) . In vitro, Y. pestis KIM5 selectively injects Yops into PMNs as well as Ms and DCs among splenic leukocytes (34) . We found no difference in the numbers of PMNs in the livers and spleens of mice infected with the parent strain of Y. pestis or the YopM Ϫ mutant, indicating that YopM does not affect the recruitment of PMNs. Ablation of PMNs and other Gr1 ϩ cells allowed a significant increase in the bacterial burden when mice were infected with the YopM Ϫ Y. pestis strain, and lesions in livers due to the YopM Ϫ bacteria resembled those from mice infected with the parent strain. These findings showed that Gr1 ϩ cells are dominant in restricting the growth of YopM Ϫ Y. pestis. Depletion of these cells also allowed some increased growth of the parent Y. pestis, likely because even the parent strain does not neutralize 100% of the Gr1 ϩ cells. PMNs were strongly depleted by the anti-Gr1 (Ly6G/Ly6C) treatment and are a prime candidate for a cell type that is important for controlling bacterial proliferation in both the liver and spleen. However, the anti-Gr1 treatment also eliminated the influx of Ly6G Ϫ Ms/monocytes into the spleen and delayed the influx into the liver, probably due to the robust expression of Ly6C on inflammatory monocytes (20) . Accordingly, these experiments pointed to the involvement of PMNs and/or inflammatory monocytes in the manifestation of the growth phenotype of YopM Ϫ Y. pestis. In contrast to the effect of anti-Gr1, treatment of mice with clodronate-liposomes to deplete Ms/DCs curtailed growth of both Y. pestis strains. As reported by other groups (4, 24) , treatment with clodronateliposomes did not deplete PMNs. Taken together, these data support the hypothesis that PMNs are critical effectors for the in vivo growth defect of YopM Ϫ Y. pestis; in contrast, Ms and/or DCs promote bacterial growth in a YopM-independent manner during the first few days of systemic plague as previously suggested (33) . Studies are currently under way to assess the role of inflammatory monocytes in controlling growth of YopM Ϫ Y. pestis. In pneumonic plague, recruitment of PMNs to the lungs and local production of proinflammatory cytokines and chemokines are delayed and do not occur for 36 to 48 h (8). We confirmed this result for the influx of inflammatory cells (Fig.  7 and data not shown for other times p.i.). In contrast, we found that there was a robust inflammatory response in skin as early as 8 h following i.d. infection mimicking fleabite. Consistent with an early difference in the inflammatory character between the two types of plague, there is a growing number of pathogenic properties that are required for full virulence in bubonic, but not pneumonic, plague (11, 12, 18) . Also, YopM was required for lethality of Y. pestis CO92 in experimental bubonic, but not pneumonic, plague in mice, consistent with our hypothesis that YopM functions to counteract the effect of PMNs on bacterial growth. There was no noticeable difference in the magnitude of PMN recruitment to the infected dermis between mice infected with the parent strain or the ⌬yopM 2 mutant, consistent with our observations in the liver and spleen with Y. pestis KIM5 and also with studies using a peritoneal We previously showed that there is a YopM-associated decrease in net message expression for proinflammatory cytokines in F4/80 ϩ cells (Ms/monocytes) as early as day 2 p.i. (25) . In part, this could have reflected a smaller contribution of inflammatory monocytes to the F4/80 ϩ population analyzed from mice infected by the parent Y. pestis KIM5 compared to the YopM Ϫ mutant. However, it likely also reflected an early effect of YopM delivered to resident Ms/DCs and raised the possibility that YopM indirectly affects PMNs by compromising cytokine production of Ms and DCs. Our attempt to test this idea by ablating nongranulocytic myeloid cells was complicated by the curtailed growth of both parent and mutant Y. pestis and the incomplete ablation by liposome-encapsulated clodronate. Discerning which cell type is the primary target for YopM's pathogenic mechanism thus is complicated, and likely more than one type is involved in mediating the overall virulence effect of YopM, possibly through cytokine cross talk that provides reciprocal stimulation of innate immune cells, like PMNs, Ms, and DCs (23, 35, 39, 54) . Figure 8 shows our model for how YopM could influence the early host response during systemic plague. Early after injection by fleabite, Y. pestis may be taken into resident dermal Ms and DCs, which support intracellular replication that amplifies the infectious dose, while protecting the yersiniae from attack by PMNs. Within the protective intracellular niche, the bacteria express genes, such as those genes encoding components of the T3SS and Yops. A local proinflammatory environment develops and recruits PMNs and monocytes. After release from the resident cells, the bacteria are now armed to survive encounters with infiltrated PMNs and inflammatory monocytes. Although the monocytes may also contribute a growth-permissive niche for the yersiniae, these cells could potentially contribute to killing the bacteria, and there is a YopM-dependent decrease in recruitment of these cells into the spleen. If the yersiniae lack YopM, PMNs will clear the bacteria. When the yersiniae express YopM, some function of PMNs will be blocked and bacterial growth will be unchecked.
Ongoing studies are aimed at identifying that function and its underlying mechanism and clarifying the roles played by monocytes, Ms, and DCs. Further work is needed to understand how the distinct responses of the liver and spleen arise and operate in host defense during plague. This study is the first to have documented these differences and has provided a foundation for future studies. 
